NextGen Healthcare, Inc.
NXGN · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $2 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -1% | -0.2% | 10.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 46.3% | 44.8% | 47.3% | 47.3% |
| EBITDA | $0 | $0 | -$0 | $0 |
| % Margin | 11% | 12.1% | -4.3% | 12.5% |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 2.9% | 3.5% | -14.1% | 4.8% |
| EPS Diluted | 0.07 | 0.09 | -0.38 | 0.12 |
| % Growth | -22.2% | 123.7% | -416.7% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |